Recombinant Pseudomonas putida Argininosuccinate synthase (argG)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. For dry ice shipping, contact us in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
argG; PputW619_1117; Argininosuccinate synthase; EC 6.3.4.5; Citrulline--aspartate ligase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-405
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Pseudomonas putida (strain W619)
Target Names
argG
Target Protein Sequence
MADVKKVVLA YSGGLDTSVI LKWLQDTYDC EVVTFTADLG QGEEVEPARA KAQAMGVKEI YIDDLREEFV RDFVFPMFRA NTVYEGEYLL GTSIARPLIA KRLIEIANET GADAISHGAT GKGNDQVRFE LGAYALKPGV KVIAPWREWD LLSREKLMDY AEKHGIPIER HGKKKSPYSM DANLLHISYE GGVLEDTWTE HEEDMWRWSV SPENAPDQAT YIELTYRNGD IVAIDGVEKS PATVLADLNR IGGANGIGRL DIVENRYVGM KSRGCYETPG GTIMLRAHRA IESITLDREV AHLKDELMPK YASLIYTGYW WSPERLMLQQ MIDASQVNVN GVVRLKLYKG NVTVVGRKSD DSLFDANIAT FEEDGGAYNQ ADAAGFIKLN ALRMRIAANK GRALL
Uniprot No.

Target Background

Database Links
Protein Families
Argininosuccinate synthase family, Type 1 subfamily
Subcellular Location
Cytoplasm.

Q&A

Basic Research Questions

  • What is Pseudomonas putida Argininosuccinate synthase (argG) and what is its biochemical role?

Argininosuccinate synthase (argG) is a key enzyme in the arginine biosynthesis pathway of Pseudomonas putida with EC number 6.3.4.5, also known as Citrulline--aspartate ligase. It catalyzes the ATP-dependent condensation of citrulline and aspartate to form argininosuccinate, which is subsequently converted to arginine by argininosuccinate lyase.

The recombinant form of P. putida argG has the following characteristics:

  • Uniprot accession: A5VZI0

  • Full protein length: 405 amino acids

  • Molecular function: Catalyzes the reaction: ATP + L-citrulline + L-aspartate → AMP + pyrophosphate + L-argininosuccinate

  • Purity: >85% (SDS-PAGE)

In P. putida (recently reclassified as P. alloputida), arginine metabolism is connected to multiple physiological functions, including biofilm formation, stress tolerance, and metabolic regulation .

  • How should recombinant P. putida argG be handled and stored in laboratory settings?

Proper handling and storage of recombinant P. putida argG is critical for maintaining enzymatic activity:

Storage ConditionRecommendationNotes
Short-term storage4°CUp to one week for working aliquots
Standard storage-20°CFor routine use
Extended storage-20°C or -80°CFor long-term preservation
Shelf life (liquid form)6 months at -20°C/-80°CDepends on buffer composition
Shelf life (lyophilized)12 months at -20°C/-80°CMore stable than liquid form

Reconstitution protocol:

  • Centrifuge the vial briefly before opening

  • Reconstitute in deionized sterile water to 0.1-1.0 mg/mL

  • Add glycerol to a final concentration of 5-50% for long-term storage

  • Make small aliquots to avoid repeated freeze-thaw cycles

  • What expression systems are typically used for producing recombinant P. putida argG?

Based on the product information, recombinant P. putida argG is typically expressed using:

  • Expression host: Yeast expression system

  • Expression region: Full length protein (residues 1-405)

  • Tag information: Variable tag types depending on manufacturing process

  • Purification method: Not explicitly stated, but likely affinity chromatography based on tag type

Alternative expression systems that have been used for P. putida proteins:

  • Homologous expression in P. putida KT2440 or its engineered derivatives such as EM383, which has been optimized for heterologous protein expression

  • E. coli-based expression systems, particularly for structural and functional studies

  • Surface display systems using autotransporters like Ag43 for specialized applications

Advanced Research Questions

  • How does argG function within the context of the broader arginine regulatory network in P. putida?

Argininosuccinate synthase operates within a complex regulatory network centered around the transcription factor ArgR:

ComponentFunctionRegulationPhysiological Impact
argGArginine biosynthesisLikely regulated by ArgRContributes to arginine production
ArgRTranscriptional regulatorActivated by arginineControls arginine metabolism and transport
argT-hisPQM operonMain arginine transporterPositively regulated by ArgRFacilitates arginine uptake
aotP-artJ operonSecondary arginine transporterPositively regulated by ArgRAlternative arginine uptake

ArgR functions as a global regulator in P. putida that responds to arginine levels and exerts widespread transcriptional control beyond just arginine metabolism. This includes:

  • Positive regulation of biotin biosynthesis genes

  • Regulation of glucose utilization pathways, particularly the conversion of gluconate to gluconate-6-P via ketogluconate

  • Negative regulation of benzoate and acetoin catabolism

  • Influence on amino acid and dipeptide transporters

This regulatory architecture positions argG at a critical junction where arginine biosynthesis connects to broader cellular physiology, including biofilm formation, stress responses, and central carbon metabolism.

  • What are the methodological approaches for studying the kinetic properties of P. putida argG?

Studying the kinetic properties of recombinant P. putida argG requires careful consideration of experimental design and statistical analysis:

Experimental approaches:

  • Spectrophotometric assays: Typically coupling the formation of argininosuccinate to NADH oxidation through auxiliary enzymes

  • Radioactive substrate assays: Using 14C-labeled citrulline or aspartate to track product formation

  • HPLC-based methods: Direct quantification of argininosuccinate formation

Statistical considerations for enzyme kinetic studies:

  • Error structure modeling: Traditional enzyme kinetic analysis often assumes additive Gaussian noise, but this can lead to simulation issues like negative reaction rates. Consider using multiplicative log-normal errors instead .

  • Model transformation approach:

    • Log-transformed model: ln(y) = ln(f(x,θ)) + ε, where ε ~ N(0,σ²)

    • This prevents negative simulated rates and better matches observed error structures in many enzyme systems

  • Optimal experimental design: Use D-optimality criteria for parameter estimation, which maximizes the determinant of the Fisher information matrix:

    • For standard Michaelis-Menten kinetics: substrate concentrations at Km and at least one high concentration (>5×Km)

    • For more complex kinetics (substrate inhibition, allosteric effects): more experimental points needed

The choice of error model significantly impacts experimental design efficiency, particularly for model discrimination problems, even when parameter estimates remain similar across models .

  • How can genetic engineering techniques be applied to study or modify argG function in P. putida?

Several cutting-edge genetic engineering approaches are applicable for investigating or manipulating argG in P. putida:

  • CRISPR-Cas9 based techniques: The ReScribe system combining recombineering and ScCas9-mediated counterselection has been successfully applied in P. putida with efficiency reaching ~90% .

  • Recombineering approaches:

    • Rec2-mediated recombineering: Uses bacterial phage recombinase expressed alongside a dominant-negative mutL allele to temporarily disable mismatch repair

    • PapRecT recombineering: An alternative recombinase system with similar efficiency (~9-10% after optimization)

    • RBS optimization strategies: Tested but showed limited improvement for Rec2 and failed for PapRecT

Recombineering SystemEfficiency (Cycle 1)Efficiency (Cycle 10)Notes
Rec2-mutL^E36K0.13-0.44%5.05-10.22%Standard system
Rec2^RBSopt-mutL^E36K^RBSopt2.26-3.10%6.82-9.82%RBS-optimized variant
PapRecT-mutL^E36K0.19-0.87%8.85-9.77%Alternative recombinase
  • Multiplex genome editing: ReScribe allows simultaneous editing of multiple genomic targets, reducing time from 6 days per mutation (standard recombineering) to 1-3 days per mutation set .

  • Knockout and complementation strategies: As demonstrated with other P. putida metabolic genes (e.g., trpDC), similar approaches could be used to study argG function through deletion and heterologous complementation .

For optimal results when designing recombineering oligonucleotides for argG modification, the following parameters should be considered:

  • Oligo length: 60 bp is optimal

  • Folding energy: ≥16 kcal/mol (higher than E. coli's optimal ~12.5 kcal/mol due to P. putida's higher GC content)

  • Phosphorothioate bonds: Not recommended as they don't improve efficiency in P. putida

  • What role does argG play in biofilm formation and stress responses in P. putida?

As a key enzyme in arginine biosynthesis, argG contributes to several physiological processes that impact biofilm formation and stress responses:

Understanding argG's role in these processes could inform strategies for biofilm control or enhancement in biotechnological applications, particularly in P. putida strains engineered for bioremediation or bioproduction purposes.

  • How does P. putida argG compare to argininosuccinate synthases from other bacterial species?

Comparative analysis of argininosuccinate synthases across bacterial species reveals evolutionary adaptations to different ecological niches:

While comprehensive comparative data specifically for P. putida argG is limited, general approaches for comparative enzyme analysis include:

Optimizing heterologous expression of P. putida argG requires addressing several factors:

  • Host selection:

    • P. putida EM383: An engineered strain with improved characteristics as a host for heterologous expression

      • Genome reduction (4.3% of genome removed)

      • Elimination of prophages and flagellar machinery

      • Enhanced oxidative stress tolerance

      • Better survival in stationary phase

      • Improved plasmid transformation and conjugation efficiency

      • Higher physiological vigor (~50% increase)

    • E. coli vs. P. putida as expression hosts:

      CharacteristicE. coliP. putida
      Growth rateHigherLower
      Media requirementsLess demandingMore versatile
      Codon usageDifferent from P. putidaNative for P. putida genes
      Disulfide bond formationLess efficientMore efficient in some strains
      Stress toleranceLowerHigher
      Post-translational modificationsMay not matchMore likely to match native patterns
  • Expression strategies:

    • Codon optimization: Particularly important when expressing in hosts with different GC content

    • Promoter selection: For P. putida, the pEM7 and pTac promoters often perform well

    • Signal peptide optimization: For secreted or surface-displayed variants

    • RBS optimization: While not always effective (as seen with Rec2/PapRecT), can improve expression in some cases

  • Surface display options (for specialized applications):

    • Autotransporter systems like Ag43 have been successfully used in P. putida

    • IgA translocator constructs may work for some proteins but require experimental verification

    • Success of specific autotransporters is protein-dependent and difficult to predict in advance

  • Purification considerations:

    • Tag selection influences purification strategy

    • His-tags are commonly used for recombinant P. putida proteins

    • Buffer composition affects stability during purification

    • Detergents may be necessary for membrane-associated variants

  • How does enzyme error structure modeling impact experimental design for argG kinetic studies?

The choice of error structure model has profound implications for experimental design in enzyme kinetic studies like those involving argG:

  • Error model comparison:

    • Traditional approach: Additive Gaussian errors (y = f(x,θ) + ε, where ε ~ N(0,σ²))

    • Alternative approach: Multiplicative log-normal errors (y = f(x,θ)·exp(ε), where ε ~ N(0,σ²))

    • Log-transformed model: ln(y) = ln(f(x,θ)) + ε

  • Impact on experimental design:

    AspectAdditive Error ModelMultiplicative Error Model
    Parameter estimationSimilar estimatesSimilar estimates
    Experimental designCan be suboptimalMore robust designs
    Simulation validityCan produce negative ratesAlways positive rates
    Model discriminationLess efficientMore efficient
    D-efficiency impactReferenceCan be substantially different
  • Practical recommendations for argG kinetic studies:

    • Use multiplicative error models or log-transformed models for more robust experimental designs

    • For Michaelis-Menten kinetics, this changes the optimal substrate concentration distribution

    • For model discrimination experiments, the impact is even more pronounced

    • This is particularly important when enzyme reaction velocities span multiple orders of magnitude

  • Statistical implications:

    • The variance of reaction rates is often dependent on the observed velocity (heteroscedasticity)

    • Log transformation makes the variance more constant across the range of measurements

    • This improves the validity of statistical tests and parameter confidence intervals

    • D-optimality criteria should be calculated based on the appropriate error model

The proper choice of error structure is crucial for designing efficient experiments that maximize information gain while minimizing the number of required measurements, particularly important for enzymes like argG where purified protein or substrate availability may be limiting factors.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.